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A hallmark of heart-valve development is the swelling and deposition of extracellular matrix in the heart-valve region. Only myocardium
overlying this region can signal to underlying endothelium and cause it to lose cell–cell contacts, delaminate, and invade the extracellular space
abutting myocardium and endocardium to form endocardial cushions (EC) in a process known as epithelial to mesenchymal transformation (EMT).
The heart-valve myocardium expresses bone morphogenetic protein-2 (Bmp2) coincident with development of valve mesenchyme. BMPs belong to
the transforming growth factor beta superfamily (TGF-β) and play a wide variety of roles during development. We show that conditional ablation of
Bmp2 in cardiac progenitors results in cell fate changes in which the heart-valve region adopts the identity of differentiated chamber myocardium.
Moreover, Bmp2-deficient hearts fail to induce production and deposition of matrix at the heart-valve-forming region, resulting in the inability of the
endothelium to swell and impairing the development of ECs. Furthermore, in collagen invasion assays, Bmp2 mutant endothelium is incapable of
undergoing EMT, and addition of BMP2 protein to mutant heart explants rescues this phenotype. Our results demonstrate thatBmp2 is both necessary
and sufficient to specify a field of cardiac progenitor cells as the heart-valve-inducing region amid developing atria and ventricles.
© 2006 Elsevier Inc. All rights reserved.Keywords: Heart development; Endocardial cushion; epithelial–mesenchymal transition, EMT; Bmp2; Atrioventricular canal, AVC; Cardiac morphogenesis; Cardiac
development; Bone morphogenetic proteinIntroduction
Proper heart chamber and valve development is essential for
life, and problems in the ontogeny of the heart valves and septa
account for a preponderance of cases of congenital heart disease
(Fishman and Chien, 1997; McFadden and Olson, 2002;
Pierpont et al., 2000). The heart-valve progenitors originate
adjoining the developing atria and ventricles in a region known
as the atrioventricular canal (AVC), in an arrangement that
prefigures the architecture of the adult cardiac chambers.
Several genes show restricted spatial expression along the
antero-posterior axis of the developing heart (Mjaatvedt, 1999).
They divide the heart into five regions: outflow tract (OT), right
ventricle, left ventricle, atria, and inflow tract (IT). Concurrent
with looping and growth of the ventricles, the ECs form and
remodel to become the OT and AV valves (Bolender and
Markwald, 1979; Fishman and Chien, 1997; McFadden and
Olson, 2002). Inductive signals from the myocardium stimulate⁎ Corresponding author.
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al., 1987). The potential to respond to these signals is unique
within the ECs, as atrial or ventricular endothelia cannot undergo
transformation in vivo or in vitro even when exposed to suitable
stimuli (Runyan and Markwald, 1983). Hence, mesenchyme
formation within the heart depends on both a localized
myocardial-inducing activity and an endothelial cell competence.
BMPs are part of the transforming growth factor beta
superfamily (TGF-β) and have a broad variety of roles during
development (Hogan, 1996). Bmp2, Bmp4 and Bmp5 are
localized temporally and spatially to the myocardium overlying
the AVC (Cai et al., 2005; Jiao et al., 2003; Lyons et al., 1990).
Conventional generation of Bmp2 null embryos results in death
by embryonic day 8.5 (Zhang and Bradley, 1996), prior to
cushion formation. This has precluded the examination of Bmp2
loss-of-function during specification of AVC and EC morpho-
genesis. Conditional ablation of Bmp4 in the myocardium
reveals that it regulates AV septation after cushions are formed
(Jiao et al., 2003). In Bmp5-deficient embryos, heart develop-
ment is normal (Kingsley et al., 1992). BMPs bind two serine/
threonine kinase receptors, type I and type II. Conditional
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hypoplasia of AV cushions, thin myocardium and down-
regulation of TGFβ2 (Gaussin et al., 2002). In these mutants,
the AVC, albeit malformed, is patterned appropriately along the
anterior–posterior axis. Recently, BMP2 protein was shown to
be sufficient to induce EMT in monolayer cultures of mouse
endothelium (Sugi et al., 2004). However, no molecule from the
BMP subfamily, their receptors or intermediates have been
implicated in the necessary upstream step of the initial
establishment of the heart-valve-forming region along the
anterior–posterior axis of the heart.
To circumvent Bmp2-deficient lethality and determine the role
of Bmp2 in chamber specification, antero-posterior heart
patterning and EC formation, we undertook a recombinase-
based approach to eliminate Bmp2 specifically in the developing
heart. Conditional ablation of Bmp2 in cardiac progenitors results
in cell fate changes, in which the heart-valve forming region
adopts the identity of differentiated chamber myocardium.
Bmp2-deficient hearts fail to induce production and deposition
of matrix at the heart-valve-forming region, resulting in the
inability of the endothelium to swell and impairing the
development of ECs. In collagen gel invasion assays, Bmp2
mutant endothelium is unable to undergo EMT, and addition of
BMP2 protein to mutant heart explants rescues this process.
Taken together, these results indicate that Bmp2 is both necessary
and sufficient for the specification of the heart-valve-inducing
region between the developing atria and ventricles.
Methods
Animals
Bmp2 floxed mice were generated in Vicki Rosen's laboratory (manuscript
in preparation). Briefly, the third exon of Bmp2 and part of its 3′UTR were
flanked by loxP sites, whose excision creates a non-functional protein. DNAwas
extracted from either tail biopsies or yolk sacs as follows: 1–2 mm of tail or one
yolk sac was placed in a screw cap 1.5-ml tube, followed by addition of 200 μl of
50 mM NaOH, incubated at 95°C for 20 min and heavily vortexed until the
material disintegrates. The preparation was quick-spun to prevent cross-
contamination, and then 50 μl of 1 M Tris pH 8.0 was added to the mixture,
mixed and spun for 5 min at maximum speed. We used 1 μl of the cleared
supernatant per PCR reaction with the addition of 1.5 μl 25 mM MgCl2 in a
25 μl reaction. Bmp2 genotyping: 5′ GTGTGGTCCACCGCATCAC and 5′
GGCAGACATTGTATCTCTAGG amplify a 474-bp product from the wild type
allele and a 545-bp product from the targeted unexcised allele. Reaction
conditions were 30 cycles of 30 s at 95°C, 30 s at 65°C and 60 s at 72°C, and Taq
(Roche) was used as the thermo-cycling polymerase. Cre genotyping: 5′
GCAGAACCTGAAGATGTTCGC and 5′ ACACCAGAGACGGAAATC-
CATC amplify a 494-bp product. Reaction conditions and DNA extractions
were as above. All mice were maintained in a mixed C57BL6/129 genetic
background. Bmp2wt/flox; Nkx2.5∷Cre+ mice were crossed with Bmp2flox/flox
mice to generate Bmp2flox/flox; Nkx2.5∷Cre+(Bmp2Nkx2.5del) mice. Matings
were timed by checking for plugs daily, with noon of the day of the plug
defined as 0.5 dpc. All experiments involving mice were approved by the
HMA Standing Committee on Animals.
Collagen gel assay for cushion mesenchyme formation
Embryos were collected in ice cold Hank's buffered saline. AV canal
explants were dissected away from isolated hearts using a gastromaster
microdissection tool (Xenotek Engineering). Explants were placed on top of
freshly prepared 1 mg/ml type I rat-tail collagen gels (BD Biosciences) inOptiMem media (Gibco), and covered with additional collagen. The collagen
sandwich was then covered with OptiMem containing 1% fetal bovine serum
and penicillin/streptomycin, supplemented with insulin/transferin/selenium (all
reagents from Gibco) (Camenisch et al., 2002b) and incubated in a tissue culture
incubator at 37°C in 5% CO2. Where indicated, 200 ng/ml of BMP2 (a gift from
Vicki Rosen) was added to the media at the start of the explant culture.
Immunohistochemistry
Immuno-detections were performed as described (Sugi et al., 2004), with the
following modifications: the primary antibodies, monoclonal anti-α-SMA-Cy3
conjugated (Clone 1A4, Sigma) and biotin-conjugated rat anti-mouse CD31
(PECAM1) monoclonal antibody (Clone MEC 13.3, BD Pharmingen), were
incubated overnight, in the dark at 4°C, followed by extensive washes in PBS.
To inactivate endogenous peroxidases, we treated explants with 0.3% H2O2 for
15 min followed by a 5 min wash in TNT (0.1 M Tris–HCl, pH 7.5, 0.15 M
NaCl, 0.05% Tween-20). The explants were blocked for at least 1 h in TNB
(0.1 M Tris–HCl, pH 7.5, 0.15 M NaCl, 0.5% Blocking reagent–Roche, and
10% heat inactivated sheep serum), followed by Strepavidin-POD antibody
(Roche, 1:500 in TNB) incubation for 30 min, and washed three times in TNT,
5 min each, at room temperature. Tyramide amplification proceeded as per
manufacturer's protocol (Molecular Probes). Fluorophore tyramide stock
solution was diluted 1:100 in amplification buffer with the addition of
0.0015% H2O2. Explants were incubated in tyramide working solution for
7 min and then washed 3 times in TNT, 5 min each, at room temperature. Nuclei
were counterstained with DAPI. Images were obtained using a Leica-SP2
confocal microscope.
Histology
Embryos were harvested in ice-cold PBS. Yolk sacs were kept for
genotyping, while embryos were fixed in 4% PFA overnight at 4°C, followed
by extensive PBS washes. Embryos were dehydrated using ethanol and
embedded in paraffin, and 10-μm sections were collected. Hematoxylin and
eosin staining was performed using standard procedures. For Alcian Blue
staining, embryos were harvested as described above. After fixation, sections
were briefly washed in distilled water and then washed for 3 min in 3% acetic
acid. Specimens were counterstained in a 5% acetic acid solution with Alcian
Blue at 0.15 mg/ml for 2 h, after which they were washed in water, mounted in
aqueous media and photographed.
In situ hybridization
Whole-mount or section in situ hybridization was performed as described
(Brent et al., 2003). DIG-labeled probes were detected with NBT/BCIP (Sigma).
For section in situ hybridization, mouse embryos were collected and sectioned as
above.Gata4,Mlc2v (Zeisberg et al., 2005), Id1 (Benezra et al., 1990), ANF and
Tbx2 (Bruneau et al., 2001) probes were synthesized as described. Notch1 was
transcribed from an EST (AW047868). TheMsx2 probe was a gift from Richard
Mass, Harvard Medical School. An 848-bp fragment of Bmp2 was generated by
RT-PCRwith the primers 5′AACTAGAAGCCGTGGAGGAACTTCCA and 5′
TTGTGGAGGGCTGCGGGTGTCGTTAG. This fragment was cloned into
pGem-T-easy vector (Promega). To synthesize the antisense probe, the vector
was linearized with Nde1, and transcribed using T7 polymerase.
Results and discussion
Bmp2 is required for endocardial swelling and heart-valve
mesenchyme formation
A cre-loxP strategy was employed in which a floxed Bmp2
allele (Bmp2flox; Rosen et al., manuscript in preparation) was
deleted in cardiac progenitors by a 3′UTR-ires-Cre allele of the
homeobox gene Nkx2.5 (Nkx2.5∷Cre) (Stanley et al., 2002).
We generated Bmp2flox/flox; Nkx2.5∷Cre+ (Bmp2Nkx2.5del)
Fig. 1. Bmp2 is required for the formation of the endocardial cushions. (A)
Control and Bmp2Nkx2.5del embryos during midgestation. Note that the
atrioventricular constriction is absent in the mutant hearts, black arrowhead.
h, Heart. (B) Differential interference contrast (DIC) microscopy of control and
Bmp2Nkx2.5del heart sagittal sections. Photographs are from the left side of the
embryos: atrial foramen (a) to the right, ventricle foramen (v) to the left, outflow
tract foramen (ot) on top. otc, outflow tract cushion; sec, superior endocardial
cushion; iec, inferior endocardial cushion. Magnification 200×. (C) Hematox-
ylin and eosin staining of sections through the heart of control and Bmp2Nkx2.5del
hearts. The red arrowheads indicate endocardial cushion mesenchyme in the
control and at the predicted location of endocardial cushions in a Bmp2Nkx2.5del
heart. Note the presence of endocardial cushion cells in the control embryos and
the absence of mesenchyme in Bmp2Nkx2.5del hearts. In addition, the
atrioventricular constriction is absent in Bmp2Nkx2.5del hearts (black arrowhead).
(D) Alcian Blue staining of acidic glycosaminoglycans. Bmp2Nkx2.5del hearts fail
to deposit extracellular matrix at the heart-valve-forming region and fail to
undergo endocardial swelling (compare blue staining, yellow arrowheads).
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progenitors causes death at 11.5 days post coitum (dpc) due
to cardiac failure. Although we never recovered embryos past
11.5 dpc, all embryos at 10.5 dpc were alive as assessed by
cardiac contractile activity at the time of harvesting. At
10.5 dpc, the AVC is barely visible on the leftside of the
control embryos because of the expanding size of the
developing chambers (Fig. 1A, left panel). At the same stage,
Bmp2Nkx2.5del embryos have an abnormally patterned heart, and
the region amid the atria and ventricles is readily visible with an
uncharacteristic, straight morphology (Fig. 1A, right panel
black arrowhead). Some of the Bmp2Nkx2.5del embryos have
cardiac edema and pericardial effusion (data not shown). In
addition, the Bmp2Nkx2.5del embryos are smaller, presumably as
a secondary consequence of their cardiovascular defects. To
analyze the morphological difference between control and
Bmp2Nkx2.5del hearts, we examined sagittal sections by differ-
ential interference contrast microscopy and hematoxylin and
eosin staining (Figs. 1B and C, respectively). In control
embryos, the forming ECs separate the atria and ventricles,
and as the chambers enlarge, the AV constriction appears at the
inner curvature of the heart (Fig. 1B and black arrowhead in Fig.
1C). The Bmp2Nkx2.5del hearts lack ECs, EC mesenchyme (red
arrowheads in Fig. 1C) and the AV constriction (compare black
arrowheads in both panels of Fig. 1C). In contrast, while the
receptor tyrosine kinases Erbb2 and Erbb3 knockout mice lack
cushion mesenchyme (Camenisch et al., 2002b), they retain
endocardial swells and normal AV constriction. The first
morphological indication of commitment of AV canal myocar-
dium to instruct the formation of the heart valves is the
deposition and swelling of the extracellular matrix. Compared
to the Erbb2 and Erbb3 defect, our Bmp2Nkx2.5del mutants arrest
at a stage prior to matrix deposition, hence before specification
of the AVC myocardium occurs, indicating that Bmp2 is
required for endocardial swelling in addition to heart-valve
mesenchyme formation. In contrast, the outflow tract of the
heart is grossly normal in Bmp2Nkx2.5del embryos. The high
contribution of neural crest mesenchyme to the development of
this structure may contribute to the absence of a phenotype in
this region.
Bmp2 is essential for extracellular matrix deposition
We investigated the possibility that Bmp2 could regulate
the increase of extracellular matrix deposition at the cushion
forming regions, which is necessary for cushion mesenchyme
formation (Camenisch et al., 2000). We examined the EC
matrix of Bmp2Nkx2.5del hearts and found no increase in
matrix deposition (yellow arrowheads, Fig. 1D) as assessed
by binding of Alcian Blue to acidic glycosaminoglycans.
The lack of matrix deposition in Bmp2Nkx2.5del ECs
phenocopies hyaluronan synthase-2 (Has2)-deficient embryos
(Camenisch et al., 2000). However, unlike our conditional
Bmp2 knockouts, Has2 mutants also display vascular
abnormalities and cardiomegaly. Therefore, it is unclear
whether the cardiac defects in the Has2 mutant are due to
loss of hyaluronan synthase-2 in the ECs or are secondary tothe vascular phenotype. In contrast, our conditional ablation
strategy takes advantage of a heart-specific promoter, which
is not expressed in the extracardiac vasculature. And indeed,
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vasculature and blood formation (data not shown). We have
demonstrated that Bmp2 is indispensable for extracellular
matrix deposition, endocardial swelling and heart-valve
mesenchyme formation.
Bmp2Nkx2.5del atrioventricular endothelium fails to initiate
EMT
Since Bmp2Nkx2.5del mutants live past stages of EC spe-
cification, we can examine the proximal tissue interactions
between myocardium and endocardium during cushion
morphogenesis at the AVC. When cultured in a collagen
lattice, AVC explants reiterate EMT (Runyan and Markwald,
1983). Using this assay we determined the stage at which
valve specification arrested in Bmp2Nkx2.5del hearts. After 48 h
in culture, control explants produced a halo of mesenchymal
cells (Fig. 2A, bright field), while Bmp2Nkx2.5del explants did
not (Fig. 2B, bright field), indicating that Bmp2 is required to
produce invasive mesenchyme. The absence of EMT in
mutant explants at 48 h in culture verifies the fact that the AV
canal is incapable of undergoing normal morphogenesis in
these animals.Fig. 2. Bmp2 is necessary and sufficient for epithelial to mesenchymal transformation
representative control explant. Immunohistochemical detection of platelet cell adhesio
are stained with DAPI in blue. The merged images are on the right. Black arrowh
transformed mesenchymal cells, and asterisks show activated untransformed endothe
magnification for confocal micrographs 400×. (B) Bmp2Nkx2.5del representative explan
lack of activated and transformed endothelium (Merge). (C) BMP2 protein can rescue
the endothelium (Merge) in Bmp2Nkx2.5del explants.BMP2 rescues EMT from AV explants deficient for Bmp2 by
inducing cell–cell separation and invasive mesenchymal cell
formation
As cardiac conditioned media can replace the requirement
for myocardium to achieve EMT in culture (Mjaatvedt and
Markwald, 1989), it has been proposed that myocardium
secretes a molecule(s) that elicits endocardial cell differentia-
tion. Bmp2 is thought to be this factor as it is only expressed in
myocardium adjoining cushion-forming segments and induces
EMT in monolayer cultures of AV endothelium (Sugi et al.,
2004). To address physiological sufficiency, a biochemical
replacement experiment was performed in Bmp2-deficient
explants. We found that addition of 200 ng/ml BMP2 to
Bmp2Nkx2.5del explants rescued cell–cell separation and invasive
mesenchymal cell formation (Fig. 2C, bright field), indicating
BMP2 is sufficient for EMT. To confirm that invasive
mesenchymal cells form, we analyzed PECAM1 and smooth
muscle alpha actin (SMA) expression to discern endothelial
from mesenchymal cells (Sugi et al., 2004). The cell adhesion
molecule PECAM1 is expressed in endothelial cells and
downregulated during EMT in the AVC (Sugi et al., 2004).
PECAM1 was maintained in endocardial cells of control,of the atrioventricular cushions. (A) Bright field and confocal micrographs of a
n molecule (PECAM, green) and anti-smooth muscle actin (a-SMA, red). Nuclei
eads indicate cells with mesenchymal morphology. Yellow arrowheads show
lial cells. e, Endothelium; m, myocardium. Magnification for bright field 6.3×;
t, note the absence of cells with mesenchymal morphology (bright field) and the
invasive mesenchyme formation (bright field), activation and transformation of
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(Figs. 2A–C, PECAM). In control explants, SMA is
expressed in invasive mesenchymal cells after EMT but not
in endocardial cells (Sugi et al., 2004) (Fig. 2A, α-SMA). No
SMA-expressing mesenchymal cells were detected in
Bmp2Nkx2.5del explants (Fig. 2B, α-SMA), and upon addition
of BMP2 to the media, SMA-positive invasive mesenchymal
cells reappeared. Co-expression of SMA and PECAM1 only
occurs in activated endothelial cells (asterisks in Figs. 2A and
C, merged) and transformed mesenchymal cells, and it is
indicative of EMT (Camenisch et al., 2002b) (yellow
arrowheads in Fig. 2A, merged). Bmp2Nkx2.5del explants
never exhibit co-expression of these markers, indicating that
BMP2 is required for AVC endothelium to undergo EMT (e
in Fig. 2B, merge). Addition of BMP2 to Bmp2Nkx2.5del
explants rescues this activation and transformation (yellow
arrowheads, Fig. 2C, merge). In order to better characterize
the extent of rescue, we counted the number of invasive cells
with mesenchyme cell morphology in all three conditions.
While Bmp2Nkx2.5del explants never undergo EMT, we find
that addition of 200 ng/ml of BMP2 to Bmp2Nkx2.5del
explants results in a 30% rescue of invasive mesenchyme
formation relative to controls, with a P value of 4 × 10−6
(Fig. 3). Although we cannot rule out the possibility that
BMP2 may have a role in controlling proliferation of the
AVC endothelium, we speculate that a mere increase in
endothelial cell numbers will not necessarily result in a
proportional increase in the formation of invasive mesen-
chyme. Local proliferation in the absence of EMT may result
in formation of a multilayered non-invasive endothelium
(Dor et al., 2001). Nevertheless, our experiments support our
initial hypothesis that BMP2 is sufficient and necessary for
inducing AVC EMT within the forming endocardial
endothelium.Fig. 3. Addition of BMP2 protein can rescue invasive mesenchyme formation.
Quantitative analysis of invasive mesenchyme formation at 48 h. One
representative experiment in shown for control (blue, n = 5), Bmp2Nkx2.5del
(red, n = 2), and rescued (green, n = 9) heart explants. The 30% rescue in
mesenchyme formation in Bmp2Nkx2.5del explants after the addition of 200 ng/ml
BMP2 is statistically significant, with a P value of 4 × 10−6.In the absence of Bmp2, the AV canal myocardium loses its
identity as primary myocardium
We have determined that the morphology of the region
between atrial and ventricular foramens in Bmp2Nkx2.5del
embryos is rather straight. The scarce matrix and close
proximity to the myocardium suggests that the endothelium
in this malformed area morphologically resembles that of the
atria and ventricles. We also have shown that the defect in
heart morphogenesis occurs prior to the increase in extracel-
lular matrix deposition at the cushion-forming region, as the
cardiac jelly never swells in Bmp2Nkx2.5del hearts. Addition-
ally, we have demonstrated that Bmp2 is both essential and
sufficient to transform AV canal endocardial cells to
mesenchyme. Taken together, the defects we observed in
morphogenesis and AVC patterning in Bmp2Nkx2.5del embryos
suggest that Bmp2 may also be required for specification of
segmental heart patterning. To investigate this, embryos were
examined at 9.5 dpc when cushion endothelium is undergoing
EMT (Camenisch et al., 2002a). Compared to controls,
Bmp2Nkx2.5del hearts have a straight morphology on the left
(compare red arrowheads Fig. 4A) and have defects with
atrial rotation. However, the OT is present and looped. To
determine if loss of Bmp2 alters gene expression in the
putative AVC region, expression of Nppa, a gene exclusive to
chamber myocardium (Christoffels et al., 2000), was
examined. In 9.5 dpc control embryos, Nppa is expressed
in myocardium of the outer curvature of the atrial and
ventricular compartments as they differentiate and balloon out
(Christoffels et al., 2000). The inner curvature forms a
continuity of myocardium with IT, AVC, and OT, but it does
not express Nppa and remains undifferentiated (Christoffels et
al., 2000) (Fig. 4F, control, red bars). In Bmp2-deficient
hearts, Nppa expression is expanded (Figs. 4C–F;
Bmp2Nkx2.5del) into the atria, IT and inner curvature of the
heart (red bars in Fig. 4C, red bars in D–F), suggesting that
loss of Bmp2 causes primitive inner curvature myocardium to
acquire the identity of differentiated outer curvature myocar-
dium. Additionally, the expression of Nppa in the putative
AVC region suggests that this heart-valve forming region has
also adopted chamber myocardium identity.
A mechanism has been proposed wherein site-specific AVC
formation results from localized repression of chamber
differentiation in the heart-valve region (Habets et al., 2002).
In this model, Tbx2, a transcriptional repressor (Jacobs et al.,
2000), forms a complex with Nkx2.5 on T-box and NK-class
elements within the Nppa promoter and suppresses Nppa
activation in the AVC and OT (Habets et al., 2002). Therefore,
we examined if misexpression of Nppa in atria, IT, and inner
curvature of Bmp2-deficient hearts could result from the loss of
Tbx2 expression. Tbx2 was expressed normally in AVC and OT
of control hearts (Christoffels et al., 2004; Habets et al., 2002)
(Figs. 4G–H, control). In Bmp2Nkx2.5del hearts, Tbx2 was absent
from the AVC and inner curvature (Fig. 4H). These data suggest
that Bmp2 instructs AVC development by regulating Tbx2
expression and is consistent with the model in which Tbx2
represses chamber myocardium fate and permits AVC
Fig. 4. Bmp2 instructs the development of the atrioventricular canal. (A, B) Control and Bmp2Nkx2.5del embryos at 9.5 days post-fertilization. (A) Left side view,
the atrioventricular constriction is absent in mutant hearts (red arrowhead). (B) Right side view, the outflow tract is patterned normally in Bmp2Nkx2.5del hearts
(red arrowhead). (C–F) Whole-mount in situ hybridization for Nppa, which marks differentiated chamber myocardium in control embryos. In Bmp2Nkx2.5del
hearts, the atrioventricular canal adopts differentiated chamber myocardium fates as judged by the expansion of Nppa into the region where the atrioventricular
canal should develop (C; compare red bars). Notice the gap of expression at the atrioventricular canal in the control embryo. (D–F) Nppa expression in control
and Bmp2Nkx2.5del hearts at 9.5 days post-fertilization. Left (D), superior (E) and inferior (F) views. The position of the atrioventricular canal is indicated by the
red bar. (G, H) Tbx2 expression in control and Bmp2Nkx2.5del hearts at 9.5 days post-fertilization. The atrioventricular canal adopts differentiated chamber
myocardium fates as judged by the absence of Tbx2 in the region where the atrioventricular canal should form (red bars in panels G and H). (I) Mlc2v
expression, which specifically marks the ventricles and AV canal, is expanded into the atrial rudiment of Bmp2Nkx2.5del hearts.
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ment, Tbx2 expression actually correlates with decreased Bmp2
signaling, rather than Tbx2 being induced by BMP activity.
These data come from several studies in which Tbx20 was
shown to be a repressor of Bmp2 (Cai et al., 2005; Singh et al.,
2005; Stennard et al., 2005). In two of these reports, the loss of
Tbx20 resulted in the downregulation of Bmp2 and yet the
upregulation of Tbx2 (Cai et al., 2005; Stennard et al., 2005).
The third group, in contrast, found concomitant upregulation of
Bmp2 and Tbx2 along the linear heart tube (Singh et al., 2005).
In all three studies, embryos deficient for Tbx20 arrest at stages
prior to cushion development, precluding the analysis of the
relation between these genes in the later setting of cushion
morphogenesis.
Bmp2 is required for specification of posterior heart structures
Prior to AV canal specification, during linear heart tube
stages, Bmp2 is strongly expressed in the posterior pole of the
heart where the atria develop; hence, it is possible that Bmp2 is
required for atrial specification. In order to test this hypothesis,
we looked at the expression of ventricular myosin light chain 2
(Mlc2v), a ventricular and AV canal-specific marker (Franco etal., 1999). In Bmp2Nkx2.5del hearts, Mlc2v expression is
expanded into the atrial region (Fig. 4I). As noted in Figs.
4C–F, Nppa expression is dramatically upregulated in the atrial
appendage of Bmp2Nkx2.5del hearts relative to controls. This high
level of expression is characteristic of ventricular myocardium.
Together, our data suggest that the atrial rudiment in
Bmp2Nkx2.5del hearts is adopting the molecular identity of
ventricular myocardium. Our mutant partially phenocopies the
LIM homeodomain transcription factor Isl1 mutant (Cai et al.,
2003). Isl1-deficient embryos lack outflow tract, right ventricle
and have mispatterned atria. Similar to our Bmp2Nkx2.5del
embryos, in Isl1-deficient embryos, Mlc2v expression is
expanded into the atrial appendage. This accompanies a
reduction in Bmp2 expression. The authors report that this
phenotype most likely arises from the failure of a particular
population of cardiac progenitors that express Isl1 to migrate
into these developing heart structures. Hence, our results
support a model in which Bmp2 is epistatic to Isl1 and
necessary for the recruitment of cardiac progenitors to the
posterior heart segments. The fact that Bmp2Nkx2.5del embryos
still have a properly patterned outflow tract and a normal right
ventricle suggests that Isl1 regulates other targets in these
anterior structures.
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hearts, we analyzed the expression of myocardial restricted
genes by section in situ hybridization. We verified that Bmp2
was inactivated by Nkx2.5∷Cre in the heart, as Bmp2 transcripts
were not detected in AVC myocardium of Bmp2Nkx2.5del hearts
but were present in controls (Fig. 5A, Bmp2Nkx2.5del, control).
Section in situ hybridization for the chamber myocardium
markers Nppa and the small muscle-specific protein SmpxFig. 5. Bmp2 is required for the AV canal myocardium to retain its identity as
primary myocardium. (A–E) Section in situ hybridization for control and
Bmp2Nkx2.5del hearts showing that the atrioventricular canal fails to be specified
in the absence of Bmp2. Note that AVC restricted transcripts are absent in
Bmp2Nkx2.5del hearts: Bmp2 (A), Tbx2 (D), Msx2 (E) and the upregulation of the
chamber specific transcripts Nppa (B) and Smpx (C) to the putative
atrioventricular canal myocardium. Black arrowheads indicate atrioventricular
canal myocardium. Insets in (B–D) are sections through the outflow portion of
the same heart. Magnification 200×. a, atria; v, ventricle; ot, outflow tract; sec,
superior endocardial cushion; iec, inferior endocardial cushion.
Fig. 6. Bmp2 is necessary to induce the endothelial cell competence to
transform. (A–C) Section in situ hybridization for control and Bmp2Nkx2.5del
hearts showing that Id1 (A), Notch1 (B), and Gata4 (C), endothelial specific
markers, are downregulated from the putative endocardial endothelium. Black
arrowheads indicate atrioventricular canal endocardium. Insets in panels B and
C are sections through the outflow portion of the same heart. Magnification
200×.(Palmer et al., 2001) confirmed the expansion of transcripts into
the heart-valve field (compare black arrowhead pairs in Figs. 5B
and C) and atria (Figs. 5B and C insets). Similar analysis for
Tbx2 verified its downregulation in the AVC (Fig. 5D). Similar
to Bmp2 and Tbx2, Msx2 (muscle segment homeobox 2)
expression is restricted to the AVC myocardium in controls
(Abdelwahid et al., 2001) (Fig. 5E, control), and downregulated
in the myocardium abutting the chambers in mutants (Fig. 5E,
Bmp2Nkx2.5del). Taken together, expansion of Nppa and Smpx
and absence of Tbx2 andMsx2 expression suggest that chamber
myocardium is specified at the expense of AVC myocardium in
Bmp2-deficient embryos.
Bmp2 maintains the molecular competence of the cardiac
endothelium, which is required to form heart-valve
mesenchyme
Because AVC myocardium induces the adjacent endotheli-
um to undergo EMT and form the valves, we examined the
expression of Id1, Notch1, and Gata4, genes that are either
present in AVC endothelium during EMT (Jen et al., 1996;
Timmerman et al., 2004; Zeisberg et al., 2005) or have been
implicated in the process (Timmerman et al., 2004) (Figs. 6A–
C, control). Expression of Id1, a negative regulator of basic
helix–loop–helix transcription factors (Jen et al., 1996), was
587J. Rivera-Feliciano, C.J. Tabin / Developmental Biology 295 (2006) 580–588absent from Bmp2Nkx2.5del heart endothelium compared to
controls (Fig. 6A, Bmp2Nkx2.5del), suggesting BMP2 regulates
Id1 expression in AVC endothelium. This finding is consistent
with other studies demonstrating that Id1 is induced by BMP2
in osteoblast-like and myoblastic cells (Katagiri et al., 1994;
Ogata et al., 1993) and is a direct target of BMP in embryonic
stem cells (Hollnagel et al., 1999).
Since the Notch1 signal transduction pathway has been
found to directly regulate genes important for endocardial EMT
(Timmerman et al., 2004), and deletion of Notch1 results in
hypocellular ECs (Timmerman et al., 2004), we examined if
Notch1 expression is altered in the absence of Bmp2. While
control hearts exhibit robust Notch1 expression in AVC
endothelium and mesenchyme (Fig. 6B, control), Bmp2Nkx2.5del
endothelium completely lacks Notch1 transcripts (Fig. 6B,
Bmp2Nkx2.5del). Although Notch1 makes endocardial endothe-
lium competent to form heart-valve mesenchyme, we find that
Bmp2 is necessary for Notch1 expression and inducing this
competence.
Gata4, a transcription factor essential for heart formation (Kuo
et al., 1997; Molkentin et al., 1997), is robustly expressed at
9.5 dpc in control AVC endocardium and ECmesenchyme, which
is mostly derived from AVC endocardium (Kisanuki et al., 2001;
Zeisberg et al., 2005) (Fig. 6C, control). Interestingly, myocardial-
specific ablation ofGata4 results in the loss of endocardialGata4
expression, indicating a paracrine signal derived from myocardi-
um regulates its endocardial expression (Zeisberg et al., 2005). In
Bmp2Nkx2.5del hearts, myocardial expression of Gata4 remains
intact while the expression in AVendothelium was lost (Fig. 6C,
Bmp2Nkx2.5del). Based on this finding, we speculate that this
paracrine signal is Bmp2. Taken together, absence of Id1, Notch1,
andGata4 expression fromBmp2-deficient endothelium suggests
that these mutants failed to acquire endothelial cell competence
for transformation. It also places Id1, Notch1, andGata4 epistatic
to Bmp2 during heart morphogenesis. Moreover, putative AVC
endothelium in Bmp2Nkx2.5del hearts has the molecular signature
of chamber endothelium. Thus, this region inBmp2Nkx2.5del hearts
has acquired chamber fates at the expense of primarymyocardium
progenitors.
Conclusion
The regional specificity of induction and the instructive
potential of Bmp2 in the myocardium of the AVC initiate a
cascade of events that establish EMT competence in the
endothelium. Despite the promiscuity of BMP ligand/receptor
binding (Ebisawa et al., 1999; ten Dijke et al., 1994), we find
that one signaling molecule, Bmp2, is essential and non-
redundant for specification of the heart-valve-forming region.
Hence, our results place Bmp2 at the top of a genetic hierarchy
essential for formation of the AVC and, consequently, for
formation of the heart valves.
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